ICM
REZI icon

Invenomic Capital Management’s Resideo Technologies REZI Stock Holding History

Invenomic Capital Management’s Portfolio REZI Stock Details REZI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-271,826
Closed -$5.47M – 177
2024
Q3 		$5.47M Buy
271,826
+198,238
+269% +$3.93M 0.3% 93
2024
Q2 		$1.44M Buy
+73,588
New +$1.52M 0.07% 152
2024
Q1 		– Sell
-162,856
Closed -$3.06M – 185
2023
Q4 		$3.06M Buy
+162,856
New +$2.67M 0.14% 129

Other funds holding REZI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invenomic Capital Management's REZI Position: Q4 2024 in Review

Invenomic Capital Management sold out of Resideo Technologies (REZI) in Q4 2024, closing a stake of 271,826 shares — an estimated $5.47M sold.

Invenomic Capital Management first reported a position in REZI in Q4 2023 and held it in 3 quarters. The position peaked at $5.47M in Q3 2024. 399 funds tracked by Wall St. Rank hold REZI as of Q4 2024.

  • Invenomic Capital Management reported no remaining Resideo Technologies position as of Q4 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 271,826 Resideo Technologies shares in Q4 2024, an estimated $5.47M.
  • Invenomic Capital Management first reported a position in Resideo Technologies in Q4 2023 and held it in 3 quarters.
  • Invenomic Capital Management's Resideo Technologies position peaked at $5.47M in Q3 2024.
  • 399 funds tracked by Wall St. Rank held Resideo Technologies as of Q4 2024.

Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.